Kura Oncology, Inc.

KURA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$224,462$37,318$51,802$90,672
Short-Term Investments$502,933$386,639$386,183$427,288
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$17,434$8,524$8,441$4,329
Total Curr. Assets$744,829$432,481$446,426$522,289
Property Plant & Equip (Net)$7,485$8,852$6,382$8,246
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$7,845$7,602$3,498$3,516
Total NC Assets$15,330$16,454$9,880$11,762
Other Assets$0$0$0$0
Total Assets$760,159$448,935$456,306$534,051
Liabilities
Payables$1,469$2,300$1,533$3,236
Short-Term Debt$4,488$1,506$2,318$2,263
Tax Payable$2,061$0$0$0
Deferred Revenue$24,271$0$0$0
Other Curr. Liab.$46,423$31,457$20,206$16,956
Total Curr. Liab.$78,712$35,263$24,057$22,455
LT Debt$12,106$15,694$11,706$4,612
Deferred Rev, NC$253,906$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,795$705$265$375
Total NC Liab.$267,807$16,399$11,971$4,987
Other Liabilities$0$0$0$0
Cap. Leases$7,071$7,868$4,866$6,875
Total Liabilities$346,519$51,662$36,028$27,442
Equity
Pref Stock$0$0$0$0
Common Stock$8$7$7$7
Retained Earnings-$895,422-$721,439-$568,808-$432,968
AOCI$764-$1,271-$8,032-$1,789
Other Equity$1,308,290$1,119,976$997,111$941,359
Total Equity$413,640$397,273$420,278$506,609
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$760,159$448,935$456,306$534,051
Net Debt-$207,868-$20,118-$37,778-$83,797